Clinical Study
High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B
Table 1
Demographic and clinical characteristics of the patients.
| | Number | Range |
| Age | 40 | 27–79 years Mean 54 years ± SD 8.94 | Gender | 40 | Male 32 (80%) Female 8 (20%) | HBSAg | 40 | 40 positive (100%) | HBSAb | 40 | 32 positive (80%) 8 negative (20%) | HBeAg | 40 | 25 positive (62.5%) 15 negative (37.5%) | HBeAb | 40 | 15 positive (37.5%) 25 negative (62.5%) |
|
|